Cannabinoids: between neuroprotection and neurotoxicity.
about
THC Prevents MDMA Neurotoxicity in MiceOpposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.Is lipid signaling through cannabinoid 2 receptors part of a protective system?Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionCannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesisAnandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.Endocannabinoids in synaptic plasticity and neuroprotection.Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects.Pathways from cannabis to psychosis: a review of the evidence.Neuroimaging revolutionizes therapeutic approaches to chronic painEndocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.White matter integrity in adolescents with histories of marijuana use and binge drinking.The dual neuroprotective-neurotoxic profile of cannabinoid drugs.Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganizationCannabis, cigarettes, and their co-occurring use: Disentangling differences in default mode network functional connectivity.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningThe cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.Cyclooxygenase-2 in synaptic signaling.The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.Dual neuroprotective and neurotoxic effects of cannabinoid drugs in vitro.Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoidsAnandamide protects from low serum-induced apoptosis via its degradation to ethanolamine.Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation.Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability.Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders.Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling.Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity.Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter.
P2860
Q21090029-F96C6899-FE9E-4FC4-BBEC-D3952F7DD688Q24602238-4FABC5CB-0366-44D8-930E-12323C5D1125Q24633122-34094AC2-3449-4674-B618-A0A6614C0C1FQ27014154-6B72BCDC-C49A-4A90-A30F-7518245CCC6EQ27497540-4B76A6A1-8CA3-4353-9A36-4A1FE9AEF5E5Q33699215-CD5BD203-DE9B-477D-AE55-3F4DCE320804Q34084682-A87D8CF2-3077-4EC3-95B2-9A024E9D93D9Q34248191-9E6931B0-AF0D-4AF9-8ACD-E0299C53FDC4Q34378233-70E2E89F-1011-4E19-8E5E-6B216240C6E0Q34582857-C5F833A7-B7E3-47ED-8895-E5EE918F583EQ34642593-87BEF26C-F379-4ED4-A23D-FBB4C793BFCAQ34994027-633332D5-6D82-4C19-B06A-319BC21CBD80Q35193273-2F7183B8-CFE0-42CA-B0DF-38824263EC05Q35193317-1D41840D-A39D-41BD-BAE0-641AAD158A5DQ35216772-14B1019C-F8D3-4A85-AAEF-F3812CEC244EQ35875536-44EA92A7-413C-4F98-9E57-657A449BAA28Q36416372-417FA8DD-C2C4-432C-AAC4-5C1B50626CBAQ36655240-4C162818-CB47-4A7F-A629-834373B312CCQ36922736-6EA6BCE4-A0F0-43A4-A85E-E99BBAACF2C4Q37522883-F24E6F1C-6BB5-4D26-913E-4F3933B46159Q37546194-774A8C7F-9AAD-408A-A3C3-6067F840EFA2Q38484913-156FE946-19E3-47DD-B235-54FBE7AA6363Q39635515-D6185B48-456D-4D65-9CFF-5D8BCAD43AA4Q39969705-206D5FB0-F2A3-4BFD-822D-D9C9462EC705Q40182562-74115D03-290F-4D30-A149-693FC91FF91CQ42178082-43CE237F-2A09-4148-B83C-DF4C44B33E4AQ42347749-3A7D5059-8D55-473D-A246-E906A5008995Q46546882-D7D16223-0B59-47CD-A144-98AEFA91C2DFQ46769024-F49083E4-F6E7-4E39-83BF-FA509D36A987Q47406095-80FEE5D3-5158-45A1-99BE-5910D6C6C078Q47850781-D9CAE8F6-945C-4920-94CC-AB9D98874317Q48144821-6D2814A7-CBFC-4EAB-B123-5A03D6BA8E35Q48150926-24BCC3A3-8026-4579-926B-63AA6F16D0C1Q54753732-8052BE66-15F3-4E54-BDCD-1BA1F7E5BCBCQ55443804-071A95A1-C1CA-4BD5-803A-16228CA4524D
P2860
Cannabinoids: between neuroprotection and neurotoxicity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cannabinoids: between neuroprotection and neurotoxicity.
@ast
Cannabinoids: between neuroprotection and neurotoxicity.
@en
type
label
Cannabinoids: between neuroprotection and neurotoxicity.
@ast
Cannabinoids: between neuroprotection and neurotoxicity.
@en
prefLabel
Cannabinoids: between neuroprotection and neurotoxicity.
@ast
Cannabinoids: between neuroprotection and neurotoxicity.
@en
P1476
Cannabinoids: between neuroprotection and neurotoxicity.
@en
P2093
Yosef Sarne
P304
P356
10.2174/156800705774933005
P577
2005-12-01T00:00:00Z